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Delivering long-term cancer care in primary care 
In 2016, there were 17.2 million incident cases of cancer globally and the number of incident 
cases increased by 28% in the preceding decade1. Similar trends are anticipated in the United 
Kingdom (UK) with 2.5 million people living with cancer in 2015 which is expected to increase to 4 
million by 20302. Ten-year survival for all cancers has more than doubled in the United Kingdom 
from 24% to 50% over the last four decades3. This is due a combination of factors including better 
diagnostic technology, screening programmes and better treatments1. Recovery after cancer and its 
treatment presents new challenges including physical problems such as overwhelming fatigue, 
psychological problems such as fear of recurrence, social problems such as loss of employment, 
and the need for supplementary information. Primary care is well placed to provide proactive care to 
help with the interlinked biopsychosocial problems that may arise after the completion of cancer 
treatment.  
There is no clear consensus where the responsibilities for care of cancer survivors, i.e. those 
living with and beyond cancer, lie on the primary-secondary-tertiary healthcare continuum. (Patients 
or clinicians do not universally adopt the term ‘survivorship’ as it implies a definite conclusion to 
treatment when this is not always clear). According to the National Cancer Research Institute 
(NCRI) and James Lind Alliance (JLA), the top priority for living with and beyond cancer research is 
to answer the question “What are the best models for delivering long-term cancer care including 
screening, diagnosing and managing long-term side effects and late-effects of cancer and its 
treatment (e.g. primary and secondary care, voluntary organisations, self-management, carer 
involvement, use of digital technology)?” The recently published European guidelines4 for quality 
cancer care in primary care highlighted the need for more evidence in primary care-led care and the 
ability for primary care to manage the long-term consequences of cancer treatment. 
This article aims to summarise the current tools used to address the consequences of 




Tools for living with and beyond cancer care 
There have been two contrasting approaches, often initiated by secondary care, to improve 
cancer follow-up care: needs assessment and survivorship care plans (SCPs) (see Useful 
Resources). Needs assessment can be subdivided into holistic needs assessments (HNA), and 
distress thermometer and problem lists (DT&PL).   
The DT&PL were developed in 1998 and consist of a distress thermometer that provides a 
quick analogue scale accompanied by a longer checklist similar to the HNAs covering several 
domains but is not common in the UK. Interviews with clinicians and patients identified that the 
DT&PL legitimised and identified distress but its efficacy as a tool was limited by lack of time, 
support services and referral guidelines8. An unblinded randomised controlled trial comparing the 
use of DT&PL to usual care (n=220) in patients with different cancer types receiving chemotherapy 
and radiotherapy revealed that the DT&PL often served as an assessment tool alone - without a 
clear triage or management plan, and did not influence patients’ mood9. However, this result could 
reflect poor trial design.  
A similar approach in use is the holistic needs assessment. The HNA was developed in the 
UK following a national drive in 2010 to move from generalised to personalised care planning. The 
HNA, which is typically initiated at the end of treatment, often via a combination of electronic input 
and face-to-face contact with a secondary care healthcare professional, is designed to provide 
tailored health interventions according to individual situations rather than isolated disease 
processes. The components include: 
• Physical concerns: fatigue, pain,  
• Practical concerns: work, finances, travel, education, being a carer for others 
• Family/relationship concerns: friends and family 
• Emotional concerns: mental health, religious and spiritual concerns 
• Lifestyle or information needs: support groups, physical activity, smoking 
4 
 
 Despite this, HNAs are implemented in only one in four people who are living with and 
beyond cancer in the UK10. From 2016 to 2018, 83% of the 62,886 HNAs conducted identified care 
needs and most HNAs were implemented at the initial diagnosis or after the completion of treatment 
(unpublished data, Macmillan). The most prevalent concerns raised by patients included: 
psychological concerns, questions regarding diagnosis, sleep problems, pain, tiredness and weight 
changes (unpublished data, Macmillan). Macmillan Cancer Support is currently evaluating the 
nationwide effectiveness and use of HNAs. In contrast to the DT&PL, the HNAs should generate a 
personalised care plan with supportive resources (see Useful Resources).  
Alternatively, survivorship care plans (SCPs) developed in 2006 as a result of US 
stakeholder collaboration involve a cancer-related treatment summary and an on-going care plan 
and aim to provide care coordination between primary care and secondary care, rather than 
identification of care needs. These are delivered directly via a one-off, face-to-face intervention with 
one or more healthcare professionals in secondary care but are sometimes posted directly to the 
healthcare professional. There is no consensus on the exact constituents of the SCP but broadly 
speaking there are five recommended domains11: 
1. Treatment summary, care co-ordination & follow-up 
2. Short & long-term effects, signs of recurrence & rehabilitation 
3. Psycho-social, and spiritual support & sexual life 
4. Health promotion, prevention, screening and genetic testing 
5. Supportive resources 
 
There have been several randomised control trials (RCTs) looking at the effects of 
survivorship care plans, which have reported no discernible benefit. A recently published systematic 
review11 confirmed this and the authors concluded that study design heterogeneity and varying 
outcome measures which did not necessarily relate to the intervention were the probable reasons 
behind this. There are several reasons why SCPs might not have shown positive outcomes, which 
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may include differences in cancer types, cancer treatment even in the same cancer type, patient 
populations; differences in intervention components, delivery and timing.  
Similar to the SCP, in the UK the secondary care team may produce a ‘treatment summary’ 
which provides patients and GPs with a single page summary of treatments, ongoing tests, financial 
support, symptoms requiring medical attention, and outstanding actions for the GP and other 
professionals involved in care. There is variable uptake nationally of this initiative, which could ease 
transition of care from the hospital to the community.  
 
Stakeholder views on the role of Primary Care  
A systematic review collating the views of patients5 and GPs6 on the role of the General 
Practitioner (GP) outlined that patients expected their GPs to provide ‘general primary care’; 
biopsychosocial care related to cancer treatment and beyond; palliative care when appropriate; 
appropriate information; and to act as an advocate for appropriate referral5. Research including the 
entire primary care team and that relating just to GPs generally comes to similar conclusions. 
European guidance4 delineated the need to use the full breadth of primary care teams from 
community pharmacists and nurses to geriatricians and palliative care physicians. Furthermore, 
policymakers must recognise the importance of unpaid carers and their needs. 
Patients wanted GPs to be better engaged in cancer care especially with specialists, to have 
access to guidelines, to be more knowledgeable in long-term cancer care, and to provide better 
support with pathways for referral and recurrence monitoring5. GPs felt a shared care model would 
provide better psychosocial support for patients and financial savings at a patient and system level6. 
However a 2015 survey found that although GPs felt that they are best placed within primary care to 
initiate and coordinate care they felt they lacked the time and knowledge to provide adequate care 
for those living with and beyond cancer7. 
Barriers to providing cancer care included limited time and resources, lack of care 
coordination with secondary care, including poor communication and inconsistent information from 
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secondary care, lack of training and time for training, and financial constraints5 6. GPs questioned 
the feasibility of implementing a proactive model compared to a reactive approach6. Such a 
proactive model called the ‘cancer care review’ has been introduced in the UK but there is danger of 
it being a ‘tick-box’ exercise without acknowledgement of the personal impact of the cancer 
diagnosis and current treatment. As a template within electronic record systems, ‘cancer care 
reviews’ are linked in the UK to payment for performance measures within 6 months of a cancer 
diagnosis being made under the Quality and Outcomes Framework (QoF). Anecdotally, the offer of 
a proactive appointment especially during treatment can legitimise patient concerns and initiate the 
start or continuation of relationship with a GP long after completion of treatment.  
 
Future Directions 
In the UK, GPs have guidelines12 for caring for those living with and beyond cancer. 
However, the awareness and implementation of this guidance in clinical practice amongst existing 
GPs is currently unknown. Identification of barriers and facilitators to delivery of this guidance, and 
perhaps the aforementioned tools, could help ensure good delivery of care by GPs who are 
postgraduate learners. Future work must identify the most effective models of care and how they 
can deliver personalised care using validated outcome measures. Primary care is already the site of 
the majority of patient contacts and will require further resources to deliver care for those living with 





• Distress Thermometer & Problem List - from National Comprehensive Cancer Network: 
https://www.nccn.org/patients/resources/life_with_cancer/pdf/nccn_distress_thermometer.pd
f 
• Holistic Needs Assessment - from London Cancer: 
http://www.londoncancer.org/media/79850/London-Holistic-Needs-Assessment_print-
version_v2.2_HW.pdf 




• Treatment Summary – from Macmillan Cancer Support: 
https://www.macmillan.org.uk/documents/aboutus/health_professionals/recoverypackage/tre
atmentsummary.pdf  
• The UK Top living with and beyond cancer research priorities: National Cancer Research 
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